Lung cancer biomarker testing

perspective from Europe

Erik Thunnissen (Author), Birgit Weynand (Author), Dalma Udovicic-Gagula (Author), Luka Brčić (Author), Malgorzata Szolkowska (Author), Paul Hofman (Author), Silvana Smojver-Ježek (Author), Sisko Anttila (Author), Fiorella Calabrese (Author), Izidor Kern (Author)

Abstract

A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future.

Keywords

pljučni rak;napovedno testiranje;lung cancer;predictive testing;

Data

Language:	English
Year of publishing:	2020
Typology:	1.02 - Review Article
Publisher:	AME Publishing
UDC:	616-006
COBISS:	28071683
ISSN:	2226-4477
Views:	990
Downloads:	659
Average score:	0 (0 votes)
Metadata:

Other data

Secondary keywords:	Lung neoplasms;Diagnosis;Therapy;Europe;Pljučne novotvorbe;Diagnostika;Terapija;Evropa;
Source comment:	Nasl. z nasl. zaslona; Soavtor iz Slovenije: Izidor Kern; Opis vira z dne 11. 9. 2020;
Pages:	str. 887-897
Volume:	ǂVol. ǂ9
Issue:	ǂiss. ǂ3
Chronology:	Jun. 2020
DOI:	10.21037/tlcr.2020.04.07
ID:	12036969